New Horizons in Menopause, Menopausal Hormone Therapy, and Alzheimer's Disease: Current Insights and Future Directions
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Menopausal hormone therapy (MHT) timing influences Alzheimer
Area Of Science
- Neuroscience
- Endocrinology
- Gerontology
Background
- Menopausal hormone therapy (MHT) effects on Alzheimer disease (AD) and dementia risk vary by initiation timing, age, and formulation.
- Randomized clinical trials (RCTs) in older women (≥65) show increased dementia risk with MHT.
- Observational studies suggest midlife estrogen-only therapy (ET) may reduce AD risk, while estrogen-progestogen therapy (EPT) shows mixed results.
Purpose Of The Study
- To review evidence on MHT's impact on Alzheimer disease (AD) and dementia risk.
- To advocate for using AD biomarkers to assess MHT's preventative potential.
- To consider MHT as a potential preventative strategy for AD, given current therapeutic limitations.
Main Methods
- Review of existing randomized clinical trials (RCTs) and observational studies on MHT and dementia.
- Discussion of utilizing Alzheimer disease (AD) biomarkers for outcome assessment.
- Analysis of MHT's risk-benefit profile in the context of AD prevention.
Main Results
- MHT initiation in older postmenopausal women (≥65) is linked to increased dementia risk.
- Midlife estrogen-only therapy (ET) use is associated with reduced Alzheimer disease (AD) risk in observational studies.
- Estrogen-progestogen therapy (EPT) shows inconsistent associations with dementia risk.
Conclusions
- MHT's influence on Alzheimer disease (AD) and dementia risk is complex and timing-dependent.
- Utilizing AD biomarkers is crucial for accurately assessing MHT's preventative efficacy.
- Further research into MHT as a time-sensitive, female-specific AD risk reduction strategy is warranted.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.